Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Yang, Ge"'
Autor:
Sufia Safina, Rebecca D. Chernock, Ezra E.W. Cohen, Stéphane Temam, Ramona F. Swaby, Nancy Y. Lee, Irene Brana, Joy Yang Ge, Arkadiy Klochikhin, Christophe Le Tourneau, Amichay Meirovitz, Robert I. Haddad, Ravindra Uppaluri, Douglas Adkins, William H. Westra, Cecilia Pinheiro
Publikováno v:
Cancer Research. 80:CT285-CT285
Background: In phase 2 studies (NCT02296684 and NCT02641093), neoadjuvant and adjuvant pembrolizumab demonstrated a pathological response (PR) and acceptable safety in patients with high-risk, resectable, LA HNSCC. KEYNOTE-689 (NCT03765918) is a rand
Autor:
Jessica L. Geiger, Ezra E.W. Cohen, Gregory A. Daniels, Ramona F. Swaby, Joy Yang Ge, Anne Lynne S. Chang, Burak Gumuscu
Publikováno v:
Cancer Research. 80:LB-138
Background: Local recurrence occurs within 5 years in ~20% of patients with high-risk locally advanced cutaneous squamous cell carcinoma treated with current standard-of-care surgical resection and adjuvant radiotherapy. Recent data with programmed d
Autor:
Dongfeng Qu, Randal May, Guangyu An, Yang Ge, Nathaniel Weygant, James J. Tomasek, Sripathi M. Sureban, Parthasarathy Chandrakesan, Edwin Bannerman-Menson, Courtney W. Houchen, Jiannan Yao, William L. Berry
Publikováno v:
Cancer Research. 77:3888-3888
Colorectal cancer (CRC) is the third leading cause of cancer death in the U.S., with only a 6% 5-yr survival rate for stage IV disease. Its spread and acquisition of resistance to chemotherapy, which are fueled by the epithelial-mesenchymal transitio
Autor:
Courtney W. Houchen, Randal May, Guangyu An, Michael J. Schlosser, Chelsea D. Ryan, Dongfeng Qu, Yang Ge, Edwin Bannerman-Menson, Nathaniel Weygant, Parthasarathy Chandrakesan
Publikováno v:
Cancer Research. 76:577-577
Introduction Pancreatic cancer is the 4th leading cause of cancer mortality in the US. Treatments for pancreatic cancer are desperately needed as current drugs lead to little or no improvement in patient survival. Doublecortin-like kinase 1 (DCLK1) m